Effect of weight loss on inflammatory indicators in obese patients with fatty liver disease

Not Applicable

• Conditions: Fatty (change of) liver; Fatty liver.

• Registration Number: IRCT2014030515105N2
• Lead Sponsor: Vice chancellor for research, Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

( Diagnosis of fatty liver disease according to increased liver enzymes and report of sonography; Body mass index equal or greater than 30; Agreement to participate in the study; Obedience to regimen) Exclusion criteria: ( Metabolic or systemic inflammatory diseases; Diabetes mellitus; Ongoing use of anti inflammatory, Immunosuppressive or metabolism affecting medications, Weight or appetite loss medications; Pregnancy; Breast feeding; Daily smoking; Disobedience to regimen)

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Weight. Timepoint: Before and just after intervention. Method of measurement: Use same scale and according to Kilogram.

Secondary Outcome Measures

Name	Time	Method
High sensitivity C- Reactive protein. Timepoint: Before and just after intervention. Method of measurement: Elisa according to Nanogram per mililiter.;Tumor necrosis factor alpha. Timepoint: Before and just after intervention. Method of measurement: Elisa according to Picogram per mililiter.;Interleukin-1beta. Timepoint: Before and just after intervention. Method of measurement: Elisa according to Picogram per mililiter.;Interleukin-6. Timepoint: Before and just after intervention. Method of measurement: Elisa according to Picogram per mililiter.